亚太地区 Omega-3 医药原料市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太地区 Omega-3 医药原料市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Feb 2023
  • Asia-Pacific
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Asia Pacific Omega 3 Ingredients For Pharmaceuticals Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 115.50 million
Diagram Market Size (Forecast Year)
USD 296.35 million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>亚太地区医药用 Omega-3 成分市场,按来源(海洋和植物)、类型(二十二碳六烯酸 (DHA)、二十碳五烯酸 (EPA)、α-亚麻酸(ALA))、形式(液体和干燥)、治疗领域(心血管疾病、自身免疫性疾病、骨骼和关节疾病、神经系统疾病、眼科疾病、皮肤健康、癌症、其他)、人群类型(成人和儿童)、分销渠道(直接、间接)划分 - 行业趋势和预测到 2030 年。

亚太地区 Omega-3 医药原料市场

亚太地区 Omega-3 医药原料市场分析及规模

消费者越来越倾向于健康饮食,包括 omega-3 成分,而且东南亚鱼油的广泛使用,这些因素预计将提高亚太地区 omega-3 的销量。目前,正在进行大量研究,预计这些研究将为多家制造商创造竞争优势,以开发用于药品的新型创新 omega-3 成分。亚太地区生活方式和与年龄相关的疾病日益增多,因此促进了补充剂和功能性食品领域的增长,收入份额达到 52%。

Data Bridge Market Research 分析了 2023-2030 年预测期内医药市场 omega-3 成分的增长率。在上述预测期内,医药市场 omega-3 成分的预期复合年增长率约为 12.5%。2022 年市场价值为 1.155 亿美元,到 2030 年将增长至 2.9635 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

亚太地区 Omega-3 药品成分市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

来源(海洋和植物)、类型(二十二碳六烯酸 (DHA)、二十碳五烯酸 (EPA)、α-亚麻酸 (ALA))、形态(液态和干态)、治疗领域(心血管疾病、自身免疫性疾病、骨骼和关节疾病、神经系统疾病、眼科疾病、皮肤健康、癌症、其他)、人群类型(成人和儿童)、分销渠道(直接、间接)

覆盖国家

亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区

涵盖的市场参与者

Avestia Pharma (India), Novasep (France), AbbVie Inc. (U.S.), KD Pharma Group (Japan), BASF SE (Germany), Corbion (Netherlands), DSM (Netherlands), AstraZeneca (U.K.), GSK plc. (U.K.), Fresenius Kabi AG (Germany), Croda International Plc (U.S.), AMARIN CORPORATION (Ireland), ANI Pharmaceuticals, Inc. (U.S.), Epax (Norway), Strides Pharma Science Limited (India), Pharma Marine AS (Norway), KinOmega Biopharm Inc. (China), Camber Pharmaceuticals, Inc. (U.S.)

Market Opportunities

  • Rising Demand of Omega-3 by Elderly Population
  • Huge growth in concentrated forms of algal omega-3 ingredients

Market Definition

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega 3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Dynamics

Drivers

  • Increasing Demand of Infants Formula

This growing demand for infant nutrition is boosting the omega-3 market in Asia-Pacific region. China and India are the world’s largest consumers of infant formula products because of high birth rates in the countries. In 2015, China resulted for about one-third of the infant formula market, while infant formula is also the largest segment of baby food in India, where an annual average of childbirth is more than 25 million children. The growing demand for high-nutritional food for infants in the developed and developing economies of Asia, such as China and India led to the further increase in the consumption of omega-3 products which in turn is estimated to increase the growth in the region. Thus, this factor increases the growth of the market.

  • Rising Technological Advancements

Technological advancements and product innovation is anticipated to boost the market for omega 3 ingredients during the forecast period. For instance, DSM introduced new 3C technology to reinvigorate omega 3 supplements category on October 6, 2016. Furthermore, on June 9, 2015, Croda introduced Incromega DHA and approved by European Food Safety Authority (EFSA). Additionally, Royal DSM collaborated with Evonik to manufacture omega 3 fatty acid products from natural marine algae for animal nutrition on March 8, 2017. This innovation will allow the production of omega 3 fatty acids for animal nutrition without using fish oil. This factor improves the market growth.

Opportunities

  • Huge growth in concentrated forms of algal omega-3 ingredients

New ultra-high concentrated omega-3 ingredients offer several benefits to consumers willing to pay a higher premium price for high-end products. Several suppliers are investing in the production of high concentrated algal omega-3 products, estimating increased demand to drive the sales. The market for concentrates has also been increasing, as more consumers become aware of the benefits of algal omega-3 and seek the benefits of higher doses. Several major companies are involved in omega-3 manufacturing that has started to strategically capitalize the existing business expansion opportunity.

  • Rising Demand of Omega-3 by Elderly Population

There is an increasing focus on healthy aging with good physical and mental function that is boosting the growth of the market. Countries, such as Japan, are experiencing a "super-aging" society in rural and urban areas. As per the 2014 estimates by Bloomberg, around 33.0% of the Japanese population was above the age of 60, 25.9% were aged 65 or above, and 12.5% were aged 75 or above. Increased blood levels of omega-3 fatty acids found in seafood are related with a higher likelihood of healthy aging among older adults. This is leading the manufacturers to develop the varieties of omega-3 ingredients in bulk. Thus, this factor helps to create much opportunities for the growth of the market.

Restraints/Challenges

  • Side Effects of omega-3 ingredients

There are various side-effects associated with the omega-3 ingredients for pharmaceuticals. Effects such as burping, diarrhea, heartburn, joint pain, stomach pain or discomfort, vomiting, constipation, nausea. Thus, these adverse effects affect the growth rate by decreasing the adoption of omega-3. This impedes the market growth.

  • Increasing Negative Consumer Perception About omega-3 ingredients

Negative consumer perception associated with the smell and taste of omega-3 ingredients is also anticipated to limit the growth of the market. These unstable fatty acids can damage through enzymatic or chemical oxidation to form compounds that give foods a fishy smell. Additionally, fresh fish oil has no fishy taste or smell, just like fresh fish. People feel hesitant to adopt for omega-3 ingredients. Thus, this hampers the market growth.

This omega-3 ingredients for pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the omega-3 ingredients for pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2021, Omega-3 related supplier GC Rieber VivoMega announced its plans to enhance production facilities and storage tanks to accommodate more ingredients in the upcoming years.
  • In 2020, DSM launched a plant-based DHA oil product, DHA SF55-O200DS oil extracted from schizochytrium algae. This product is utilized for enhancing the nutrition in mothers and infants. This new product launch by DSM increased its product portfolio in nutrition business thus, increased demand for its product in the market causes increased revenue in future.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Scope

The Omega-3 ingredients for pharmaceuticals market is segmented on the basis of source, type, forms, therapeutic areas, population type, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

  • Marine
  • Plant

Type

  • Docosahexaenoic Acid (DHA)
  • Eicosapentaenoic Acid (EPA)
  • Alpha-Linolenic Acid (ALA)

Forms

  • Liquid
  • Dry

Therapeutic Areas

  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Bone & Joint Disorders
  • Neurological Disorders
  • Ophthalmic Disorders
  • Skin Health
  • Cancer
  • Others

Population Type

  • Adults
  • Children

Distribution Channel

  • Direct
  • Indirect

Omega-3 Ingredients for Pharmaceuticals Market Regional Analysis/Insights

The Omega-3 ingredients for pharmaceuticals market is analyzed and market size insights and trends are provided by source, type, forms, therapeutic areas, population type, and distribution channel as referenced above.

The major countries covered in the Omega-3 ingredients for pharmaceuticals market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

由于消费者对植物性 omega-3 产品的需求增加,中国在市场上处于领先地位。omega 3 DHA 对婴儿神经系统、视力和大脑发育的重要性日益增加,再加上该产品支持长期健康的能力,预计将在未来几年推动市场增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了亚太地区品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

亚太地区 Omega-3 医药原料市场竞争格局及份额分析

药品用 Omega-3 成分市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对药品用 Omega-3 成分市场的关注有关。

药品 Omega-3 成分市场的主要参与者包括:

  • Avestia Pharma(印度)
  • Novasep(法国)
  • AbbVie Inc.(美国)
  • KD制药集团(日本)
  • 巴斯夫公司(德国)
  • Corbion(荷兰)
  • 帝斯曼(荷兰)
  • 阿斯利康(英国)
  • 葛兰素史克公司(英国)
  • 费森尤斯卡比公司(德国)
  • Croda International Plc(美国)
  • AMARIN CORPORATION(爱尔兰)
  • ANI Pharmaceuticals, Inc.(美国)
  • Epax(挪威)
  • Strides Pharma Science Limited(印度)
  • Pharma Marine AS(挪威)
  • KinOmega Biopharm Inc. (中国)
  • Camber Pharmaceuticals, Inc.(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific omega-3 ingredients for pharmaceuticals market size will be worth USD 296.35 million by 2030.
The growth rate of the Asia-Pacific omega-3 ingredients for pharmaceuticals market is 12.5%.
Increasing demand of infants formula & rising technological advancements are the growth drivers of the Asia-Pacific omega-3 ingredients for pharmaceuticals market.
Source, type, forms, therapeutic areas, population type, and distribution channel are the factors on which the Asia-Pacific omega-3 ingredients for pharmaceuticals market research is based.
Major companies in the Asia-Pacific omega-3 ingredients for pharmaceuticals market are Avestia Pharma (India), Novasep (France), AbbVie Inc. (U.S.), KD Pharma Group (Japan), BASF SE (Germany), Corbion (Netherlands), DSM (Netherlands), AstraZeneca (U.K.), GSK plc. (U.K.), Fresenius Kabi AG (Germany), Croda International Plc (U.S.), AMARIN CORPORATION (Ireland), ANI Pharmaceuticals, Inc. (U.S.), Epax (Norway), Strides Pharma Science Limited (India), Pharma Marine AS (Norway), KinOmega Biopharm Inc. (China), Camber Pharmaceuticals, Inc. (U.S.).